US Bancorp’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.98K | Sell |
436
-1,184
| -73% | -$18.9K | ﹤0.01% | 3529 |
|
|
2025
Q1 | $27.7K | Sell |
1,620
-137
| -8% | -$2.34K | ﹤0.01% | 3018 |
|
|
2024
Q4 | $43.5K | Buy |
1,757
+58
| +3% | +$1.44K | ﹤0.01% | 2801 |
|
|
2024
Q3 | $48.4K | Sell |
1,699
-596
| -26% | -$17K | ﹤0.01% | 2753 |
|
|
2024
Q2 | $60.6K | Sell |
2,295
-241
| -10% | -$6.36K | ﹤0.01% | 2569 |
|
|
2024
Q1 | $81.9K | Sell |
2,536
-531
| -17% | -$17.2K | ﹤0.01% | 2456 |
|
|
2023
Q4 | $129K | Buy |
3,067
+77
| +3% | +$3.24K | ﹤0.01% | 2225 |
|
|
2023
Q3 | $115K | Buy |
2,990
+31
| +1% | +$1.19K | ﹤0.01% | 2083 |
|
|
2023
Q2 | $56.1K | Sell |
2,959
-43
| -1% | -$816 | ﹤0.01% | 2428 |
|
|
2023
Q1 | $46.6K | Buy |
3,002
+43
| +1% | +$667 | ﹤0.01% | 2555 |
|
|
2022
Q4 | $52.5K | Buy |
2,959
+1,582
| +115% | +$28.1K | ﹤0.01% | 2495 |
|
|
2022
Q3 | $8K | Buy |
1,377
+731
| +113% | +$4.25K | ﹤0.01% | 3432 |
|
|
2022
Q2 | $3K | Buy |
646
+11
| +2% | +$51 | ﹤0.01% | 3711 |
|
|
2022
Q1 | $3K | Sell |
635
-302
| -32% | -$1.43K | ﹤0.01% | 3719 |
|
|
2021
Q4 | $8K | Sell |
937
-115
| -11% | -$982 | ﹤0.01% | 3479 |
|
|
2021
Q3 | $9K | Buy |
+1,052
| New | +$9K | ﹤0.01% | 3454 |
|